A 68-year-old woman is diagnosed with osteoporosis after a DXA scan (T-score -2.8 at the hip). She has no history of fractures. She is postmenopausal for 15 years. According to NICE guidance, which of the following is the most appropriate first-line pharmacological treatment to reduce fracture risk?